Page last updated: 2024-08-21

eriodictyol and chrysoeriol

eriodictyol has been researched along with chrysoeriol in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's0 (0.00)29.6817
2010's4 (57.14)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Baird, WM; Cassady, JM; Cook, VM; Ho, DK; Liu, YL1
Ash, K; Grohmann, K; Manthey, CL; Manthey, JA; Montanari, A1
Itoh, T; Sakakibara, H; Shimoi, K; Takemura, H; Yamamoto, K1
Li, J; Li, N; Ling, J; Tang, Y; Wang, W; Zhang, N; Zhang, P; Zhang, X1
Fernandes, E; Fernandes, PA; Freitas, M; Oliveira, A; Proença, C; Ramos, MJ; Ribeiro, D; Silva, AMS; Sousa, JLC1
Fernandes, E; Freitas, M; Porto, G; Ribeiro, D; Silva, AM; Tomé, SM1
Cabrita, EJ; Fernandes, E; Freitas, M; Marques, MM; Porto, G; Ribeiro, D; Silva, AM; Tomé, SM1

Other Studies

7 other study(ies) available for eriodictyol and chrysoeriol

ArticleYear
Isolation of potential cancer chemopreventive agents from Eriodictyon californicum.
    Journal of natural products, 1992, Volume: 55, Issue:3

    Topics: Animals; Anticarcinogenic Agents; Benzo(a)pyrene; Cells, Cultured; Cricetinae; Depression, Chemical; DNA, Neoplasm; Female; Flavonoids; Plants, Medicinal; Pregnancy

1992
Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes.
    Journal of natural products, 1999, Volume: 62, Issue:3

    Topics: Citrus; Cyclic AMP; Flavonoids; Humans; In Vitro Techniques; Lipopolysaccharides; Monocytes; Phosphodiesterase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha

1999
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
    Bioorganic & medicinal chemistry, 2010, Sep-01, Volume: 18, Issue:17

    Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Flavonoids; Humans; Models, Molecular; Structure-Activity Relationship

2010
Potential therapeutic agents for circulatory diseases from Bauhinia glauca Benth.subsp. pernervosa. (Da Ye Guan Men).
    Bioorganic & medicinal chemistry letters, 2015, Aug-15, Volume: 25, Issue:16

    Topics: Animals; Bauhinia; Blood Platelets; Flavonoids; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Medicine, Chinese Traditional; Plant Extracts; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Structure-Activity Relationship

2015
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
    Journal of natural products, 2020, 05-22, Volume: 83, Issue:5

    Topics: Drug Design; Enzyme Inhibitors; Flavonoids; Fructose; Fructose-Bisphosphatase; Humans; Hypoglycemic Agents; Liver; Molecular Structure

2020
Modulation of human neutrophils' oxidative burst by flavonoids.
    European journal of medicinal chemistry, 2013, Volume: 67

    Topics: Flavonoids; Humans; Luminescent Measurements; Molecular Structure; Neutrophils; Oxidation-Reduction

2013
Inhibition of LOX by flavonoids: a structure-activity relationship study.
    European journal of medicinal chemistry, 2014, Jan-24, Volume: 72

    Topics: Dose-Response Relationship, Drug; Flavonoids; Glycine max; Humans; Leukotriene B4; Lipoxygenase; Molecular Structure; Neutrophils; Structure-Activity Relationship

2014